Everolimus-eluting stents: update on current clinical studies
Dominic J Allocco, Anita A Joshi, Keith D DawkinsBoston Scientific Corporation, Natick, MA, USAAbstract: Everolimus-eluting stents (EES) have become the most commonly implanted coronary stents worldwide. This review describes and analyzes the clinical data supporting the use of EES, focusing primari...
Guardado en:
Autores principales: | Allocco DJ, Joshi AA, Dawkins KD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f0486b7a1564f68bdeed40109681f26 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Everolimus-eluting coronary stents
por: Alejandro Saez, et al.
Publicado: (2010) -
The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
por: Sanchez OD, et al.
Publicado: (2014) -
Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
por: Panoulas VF, et al.
Publicado: (2015) -
Long-term effectiveness and safety of sirolimus drug-eluting stents
por: Bikkina M, et al.
Publicado: (2011) -
Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent
por: Jonathan Bridges, et al.
Publicado: (2008)